Skip to main content
Top
Published in: Clinical Journal of Gastroenterology 3/2024

Open Access 25-03-2024 | Endocarditis | Case Report

Calcium polystyrene sulfonate-induced rectal ulcer causing E. coli native-valve infective endocarditis

Authors: Shinnosuke Fukushima, Hideharu Hagiya, Hiroyuki Honda, Tomoharu Ishida, Ryohei Shoji, Kou Hasegawa, Fumio Otsuka

Published in: Clinical Journal of Gastroenterology | Issue 3/2024

Login to get access

Abstract

Escherichia coli-associated native-valve infective endocarditis is a rare disease that affects elderly patients with underlying risk factors such as diabetes mellitus, malignancy, and renal failure. Long-term use of calcium polystyrene sulfonate is a potential risk factor for gastrointestinal mucosal damage or even colorectal ulcers. Herein, we describe a fatal case of a 66-year-old Japanese man with diabetes mellitus and renal failure who was prescribed calcium polystyrene sulfonate (CPS) for 11 years and developed a CPS-induced rectal ulcer, leading to E. coli native-valve infective endocarditis. The patient was admitted to our hospital due to acute-onset impaired consciousness. As a result of the systemic investigation, he was diagnosed with E. coli bacteremia accompanied by multiple cerebral infarctions and an acute hemorrhagic rectal ulcer. Transesophageal echocardiography revealed a 20-mm vegetative structure on the mitral valve, resulting in a final diagnosis of E. coli-associated infective endocarditis. After rectal resection, mitral valve replacement surgery was performed; however, the patient died shortly after surgery. Pathological findings of the resected rectum showed deposition of a basophilic crystalline material suggesting the presence of CPS. Our case highlights the potential risk of colorectal ulcers in a long-term CPS user, which can trigger bacterial translocation and endocarditis as fatal complications.
Literature
1.
go back to reference Laupland KB, Pasquill K, Parfitt EC, et al. Burden of community-onset bloodstream infections, Western Interior, British Columbia, Canada. Epidemiol Infect. 2016;144:2440–6.CrossRefPubMed Laupland KB, Pasquill K, Parfitt EC, et al. Burden of community-onset bloodstream infections, Western Interior, British Columbia, Canada. Epidemiol Infect. 2016;144:2440–6.CrossRefPubMed
2.
go back to reference Kobayashi T, Ikeda M, Okada Y, et al. Clinical and microbiological characteristics of recurrent Escherichia coli bacteremia. Microbiol Spectr. 2021;9: e0139921.CrossRefPubMed Kobayashi T, Ikeda M, Okada Y, et al. Clinical and microbiological characteristics of recurrent Escherichia coli bacteremia. Microbiol Spectr. 2021;9: e0139921.CrossRefPubMed
3.
go back to reference Akuzawa N, Kurabayashi M. Native valve endocarditis due to Escherichia coli infection: a case report and review of the literature. BMC Cardiovasc Disord. 2018;18:195.CrossRefPubMedPubMedCentral Akuzawa N, Kurabayashi M. Native valve endocarditis due to Escherichia coli infection: a case report and review of the literature. BMC Cardiovasc Disord. 2018;18:195.CrossRefPubMedPubMedCentral
4.
go back to reference Morpeth S, Murdoch D, Cabell CH, et al. Non-HACEK gram-negative bacillus endocarditis. Ann Intern Med. 2007;147:829–35.CrossRefPubMed Morpeth S, Murdoch D, Cabell CH, et al. Non-HACEK gram-negative bacillus endocarditis. Ann Intern Med. 2007;147:829–35.CrossRefPubMed
5.
go back to reference Branger S, Casalta JP, Habib G, et al. Escherichia coli endocarditis: seven new cases in adults and review of the literature. Eur J Clin Microbiol Infect Dis. 2005;24:537–41.CrossRefPubMed Branger S, Casalta JP, Habib G, et al. Escherichia coli endocarditis: seven new cases in adults and review of the literature. Eur J Clin Microbiol Infect Dis. 2005;24:537–41.CrossRefPubMed
6.
go back to reference Micol R, Lortholary O, Jaureguy F, et al. Escherichia coli native valve endocarditis. Clin Microbiol Infect. 2006;12:401–3.CrossRefPubMed Micol R, Lortholary O, Jaureguy F, et al. Escherichia coli native valve endocarditis. Clin Microbiol Infect. 2006;12:401–3.CrossRefPubMed
7.
go back to reference Leonard MF, Rodriguez-Villalobos H, Boisen N, et al. The causal relationship between O2:K7:H6 extra-intestinal pathogenic Escherichia coli (ExPEC) and native valve endocarditis: a case report. BMC Infect Dis. 2021;21:370.CrossRefPubMedPubMedCentral Leonard MF, Rodriguez-Villalobos H, Boisen N, et al. The causal relationship between O2:K7:H6 extra-intestinal pathogenic Escherichia coli (ExPEC) and native valve endocarditis: a case report. BMC Infect Dis. 2021;21:370.CrossRefPubMedPubMedCentral
8.
go back to reference Lupse M, Flonta M, Straut M, et al. Recurrent Infective endocarditis of the native aortic valve due to ESBL producing Escherichia coli (E. coli) after therapeutic ERCP. J Gastrointestin Liver Dis. 2012;21:217–9.PubMed Lupse M, Flonta M, Straut M, et al. Recurrent Infective endocarditis of the native aortic valve due to ESBL producing Escherichia coli (E. coli) after therapeutic ERCP. J Gastrointestin Liver Dis. 2012;21:217–9.PubMed
9.
go back to reference Piwchan S, Sripariwuth E, Sitthichaiyakul P. Calcium polystyrene sulfonate associated colonic mucosal injury-innocent bystander or pathogenic culprit? A case report and literature review. Ann Coloproctol. 2022;38:453–6.CrossRefPubMed Piwchan S, Sripariwuth E, Sitthichaiyakul P. Calcium polystyrene sulfonate associated colonic mucosal injury-innocent bystander or pathogenic culprit? A case report and literature review. Ann Coloproctol. 2022;38:453–6.CrossRefPubMed
10.
go back to reference Chan RH, Lin WH. Calcium polystyrene sulfonate-related colonic necrosis. N Engl J Med. 2023;388:164.CrossRefPubMed Chan RH, Lin WH. Calcium polystyrene sulfonate-related colonic necrosis. N Engl J Med. 2023;388:164.CrossRefPubMed
11.
go back to reference Kim T, de Oliveira Silva Lautenschlager S, Ma Q, et al. Drug crystal-related gastrointestinal complications involve crystal-induced release of neutrophil and monocyte extracellular traps. Cells. 2020;9:2481.CrossRefPubMedPubMedCentral Kim T, de Oliveira Silva Lautenschlager S, Ma Q, et al. Drug crystal-related gastrointestinal complications involve crystal-induced release of neutrophil and monocyte extracellular traps. Cells. 2020;9:2481.CrossRefPubMedPubMedCentral
12.
go back to reference Lin CK, Liang CC, Chang HT, et al. Acute hemorrhagic rectal ulcer: an important cause of lower gastrointestinal bleeding in the critically ill patients. Dig Dis Sci. 2011;56:3631–7.CrossRefPubMed Lin CK, Liang CC, Chang HT, et al. Acute hemorrhagic rectal ulcer: an important cause of lower gastrointestinal bleeding in the critically ill patients. Dig Dis Sci. 2011;56:3631–7.CrossRefPubMed
13.
go back to reference Vijayakumar C, Balagurunathan K, Prabhu R, et al. Stercoral ulcer not always indolent: a rare complication of fecal impaction. Cureus. 2018;10(5): e2613.PubMedPubMedCentral Vijayakumar C, Balagurunathan K, Prabhu R, et al. Stercoral ulcer not always indolent: a rare complication of fecal impaction. Cureus. 2018;10(5): e2613.PubMedPubMedCentral
Metadata
Title
Calcium polystyrene sulfonate-induced rectal ulcer causing E. coli native-valve infective endocarditis
Authors
Shinnosuke Fukushima
Hideharu Hagiya
Hiroyuki Honda
Tomoharu Ishida
Ryohei Shoji
Kou Hasegawa
Fumio Otsuka
Publication date
25-03-2024
Publisher
Springer Nature Singapore
Published in
Clinical Journal of Gastroenterology / Issue 3/2024
Print ISSN: 1865-7257
Electronic ISSN: 1865-7265
DOI
https://doi.org/10.1007/s12328-024-01949-4

Other articles of this Issue 3/2024

Clinical Journal of Gastroenterology 3/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine